Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 24

1.

Restoring the balance: immunotherapeutic combinations for autoimmune disease.

Smilek DE, Ehlers MR, Nepom GT.

Dis Model Mech. 2014 May;7(5):503-13. doi: 10.1242/dmm.015099.

PMID:
24795433
[PubMed - in process]
Free PMC Article
2.

Risk factors and primary prevention trials for type 1 diabetes.

Wu YL, Ding YP, Gao J, Tanaka Y, Zhang W.

Int J Biol Sci. 2013 Jul 18;9(7):666-79. doi: 10.7150/ijbs.6610. Print 2013. Review.

PMID:
23904791
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Immune-directed therapy for type 1 diabetes at the clinical level: the Immune Tolerance Network (ITN) experience.

Ehlers MR, Nepom GT.

Rev Diabet Stud. 2012 Winter;9(4):359-71. doi: 10.1900/RDS.2012.9.359. Epub 2012 Dec 28. Review.

PMID:
23804273
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Characterization of a surrogate murine antibody to model anti-human CD3 therapies.

Dépis F, Hatterer E, Ballet R, Daubeuf B, Cons L, Glatt S, Reith W, Kosco-Vilbois M, Dean Y.

MAbs. 2013 Jul-Aug;5(4):555-64. doi: 10.4161/mabs.24736. Epub 2013 Apr 18.

PMID:
23751612
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Progress in immune-based therapies for type 1 diabetes.

von Herrath M, Peakman M, Roep B.

Clin Exp Immunol. 2013 May;172(2):186-202. doi: 10.1111/cei.12085. Review.

PMID:
23574316
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Transient B-cell depletion with anti-CD20 in combination with proinsulin DNA vaccine or oral insulin: immunologic effects and efficacy in NOD mice.

Sarikonda G, Sachithanantham S, Manenkova Y, Kupfer T, Posgai A, Wasserfall C, Bernstein P, Straub L, Pagni PP, Schneider D, Calvo TR, Coulombe M, Herold K, Gill RG, Atkinson M, Nepom G, Ehlers M, Staeva T, Garren H, Steinman L, Chan AC, von Herrath M.

PLoS One. 2013;8(2):e54712. doi: 10.1371/journal.pone.0054712. Epub 2013 Feb 6.

PMID:
23405091
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Broadening the translational immunology landscape.

Peakman M.

Clin Exp Immunol. 2012 Dec;170(3):249-53. doi: 10.1111/j.1365-2249.2012.04671.x.

PMID:
23121665
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Development of standardized insulin treatment protocols for spontaneous rodent models of type 1 diabetes.

Grant CW, Duclos SK, Moran-Paul CM, Yahalom B, Tirabassi RS, Arreaza-Rubin G, Spain LM, Guberski DL.

Comp Med. 2012 Oct;62(5):381-90.

PMID:
23114041
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Antibody combination therapy targeting CD25, CD70 and CD8 reduces islet inflammation and improves glycaemia in diabetic mice.

Alkhamis T, Barbic J, Crnogorac-Jurcevic T, Greenlaw RE, Peakman M, Jurcevic S.

Clin Exp Immunol. 2012 Nov;170(2):139-48. doi: 10.1111/j.1365-2249.2012.04651.x.

PMID:
23039884
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Reversal of autoimmune diabetes by restoration of antigen-specific tolerance using genetically modified Lactococcus lactis in mice.

Takiishi T, Korf H, Van Belle TL, Robert S, Grieco FA, Caluwaerts S, Galleri L, Spagnuolo I, Steidler L, Van Huynegem K, Demetter P, Wasserfall C, Atkinson MA, Dotta F, Rottiers P, Gysemans C, Mathieu C.

J Clin Invest. 2012 May 1;122(5):1717-25. doi: 10.1172/JCI60530. Epub 2012 Apr 9.

PMID:
22484814
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Antigen targets of type 1 diabetes autoimmunity.

Roep BO, Peakman M.

Cold Spring Harb Perspect Med. 2012 Apr;2(4):a007781. doi: 10.1101/cshperspect.a007781. Review.

PMID:
22474615
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

The novel therapeutic effect of phosphoinositide 3-kinase-γ inhibitor AS605240 in autoimmune diabetes.

Azzi J, Moore RF, Elyaman W, Mounayar M, El Haddad N, Yang S, Jurewicz M, Takakura A, Petrelli A, Fiorina P, Ruckle T, Abdi R.

Diabetes. 2012 Jun;61(6):1509-18. doi: 10.2337/db11-0134. Epub 2012 Mar 8.

PMID:
22403300
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Breakdown in peripheral tolerance in type 1 diabetes in mice and humans.

Jeker LT, Bour-Jordan H, Bluestone JA.

Cold Spring Harb Perspect Med. 2012 Mar;2(3):a007807. doi: 10.1101/cshperspect.a007807. Review.

PMID:
22393537
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Combining antigen-based therapy with GABA treatment synergistically prolongs survival of transplanted ß-cells in diabetic NOD mice.

Tian J, Dang H, Kaufman DL.

PLoS One. 2011;6(9):e25337. doi: 10.1371/journal.pone.0025337. Epub 2011 Sep 22.

PMID:
21966502
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Recurrence of autoimmunity in pancreas transplant patients: research update.

Pugliese A, Reijonen HK, Nepom J, Burke GW 3rd.

Diabetes Manag (Lond). 2011 Mar;1(2):229-238.

PMID:
21927622
[PubMed]
Free PMC Article
16.

Immune intervention in type 1 diabetes.

Michels AW, Eisenbarth GS.

Semin Immunol. 2011 Jun;23(3):214-9. doi: 10.1016/j.smim.2011.07.003. Epub 2011 Aug 17. Review.

PMID:
21852151
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

2011 Update: antigen-specific therapy in type 1 diabetes.

Michels AW, von Herrath M.

Curr Opin Endocrinol Diabetes Obes. 2011 Aug;18(4):235-40. doi: 10.1097/MED.0b013e32834803ae. Review.

PMID:
21844706
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Antigen-based therapy with glutamic acid decarboxylase (GAD) vaccine in patients with recent-onset type 1 diabetes: a randomised double-blind trial.

Wherrett DK, Bundy B, Becker DJ, DiMeglio LA, Gitelman SE, Goland R, Gottlieb PA, Greenbaum CJ, Herold KC, Marks JB, Monzavi R, Moran A, Orban T, Palmer JP, Raskin P, Rodriguez H, Schatz D, Wilson DM, Krischer JP, Skyler JS; Type 1 Diabetes TrialNet GAD Study Group.

Lancet. 2011 Jul 23;378(9788):319-27. doi: 10.1016/S0140-6736(11)60895-7. Epub 2011 Jun 27.

PMID:
21714999
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Recurrence of autoimmunity following pancreas transplantation.

Burke GW 3rd, Vendrame F, Pileggi A, Ciancio G, Reijonen H, Pugliese A.

Curr Diab Rep. 2011 Oct;11(5):413-9. doi: 10.1007/s11892-011-0206-y. Review.

PMID:
21660419
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Antigen-based immune therapeutics for type 1 diabetes: magic bullets or ordinary blanks?

Culina S, Boitard C, Mallone R.

Clin Dev Immunol. 2011;2011:286248. doi: 10.1155/2011/286248. Epub 2011 May 14.

PMID:
21647401
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk